Related by context. Frequent words. (Click for all words.) 72 AUXL 71 Pluristem Therapeutics Inc. 70 CYTX 70 SGMO 69 Sunesis Pharmaceuticals Inc. 69 Inc Therapeutic Competitors 69 Idera Pharmaceuticals 68 IMMU 68 ALNY 68 ALTH 67 Rexahn Pharmaceuticals Inc. 67 SGEN 67 RPRX 67 DYAX 67 IMGN 67 RegeneRx Biopharmaceuticals Inc. 67 Calls Purchased 66 REGN 66 GTXI 66 DCTH 66 Nasdaq ALTH 66 Lexicon Pharmaceuticals 66 AKRX 66 Cyclacel Pharmaceuticals Inc. 66 Rexahn Pharmaceuticals 66 GERN 66 AFFY 66 INCY 66 NASDAQ CRXL 65 Barrier Therapeutics Inc. 65 Aastrom Biosciences 65 VICL 65 BMRN 65 Guides FY# Quick Facts 65 Sangamo BioSciences 65 BPAX 65 Q2 Loss Narrows 65 OXGN 65 PRXL 65 NovaBay Pharmaceuticals Inc. 65 QGEN 65 Metabasis Therapeutics Inc. 65 SVNT 64 EXAS 64 Cerus Corporation 64 ARYx Therapeutics Inc. 64 NASDAQ ARIA 64 Halozyme Therapeutics 64 NASDAQ STEM 64 Detects Unusual Activity 64 Ardea Biosciences 64 Sunesis Pharmaceuticals 64 ALTI 64 XOMA Ltd. 64 Nasdaq ITMN 64 Opexa Therapeutics Inc. 64 ImmunoGen Inc. 64 SCLN 64 Healthnostics Inc. 64 Acadia Pharmaceuticals 64 Rosetta Genomics Ltd. 64 VPHM 64 AVEO Pharmaceuticals Inc. 64 Presents Positive 64 ImmunoCellular Therapeutics 64 Idera Pharmaceuticals Inc. 64 IMPAX Laboratories Inc. 64 CRME 64 Genaera Corporation 64 EPIX Pharmaceuticals Inc. 63 Affymax Inc. 63 SciClone Pharmaceuticals 63 Protalix BioTherapeutics Inc. 63 Idenix Pharmaceuticals Inc. 63 MDVN 63 Vicor Technologies 63 Anadys Pharmaceuticals 63 Anadys Pharmaceuticals Inc. 63 Inc. NASDAQ BIIB 63 BMTI 63 Ariad Pharmaceuticals 63 Palatin Technologies Inc. 63 Adherex Technologies Inc. 63 Immunomedics Inc. 63 Altus Pharmaceuticals Inc. 63 VIA Pharmaceuticals 63 Q1 Loss Narrows 63 Q3 Loss Narrows 63 Adeona Pharmaceuticals Inc. 63 Neoprobe Corporation 63 Nasdaq VRTX 63 Idenix Pharmaceuticals 63 ADVENTRX Pharmaceuticals Inc. 62 Downtrend Spotted 62 Bearish Pressure Building 62 Stock Upgraded 62 Ironwood Pharmaceuticals Inc. 62 Electro Optical Sciences 62 Skymark Research Initiates Independent 62 Inovio Biomedical Corporation 62 Nasdaq REGN